CAS: 168266-51-1 - Vofopitant dihydrochloride
Fórmula:C21H25Cl2F3N6O
InChI:InChI=1/C21H23F3N6O.2ClH/c1-31-18-10-9-16(30-20(21(22,23)24)27-28-29-30)12-15(18)13-26-17-8-5-11-25-19(17)14-6-3-2-4-7-14;;/h2-4,6-7,9-10,12,17,19,25-26H,5,8,11,13H2,1H3;2*1H
- Sinónimos:
- 3-Piperidinamine, N-[[2-methoxy-5-[5-(trifluoro-methyl)-1H-tetrazol-1-yl]phenyl]methyl]-2-phenyl-, dihydrochloride, (2S,3S)-
- 3-Piperidinamine, N-[[2-methoxy-5-[5-(trifluoromethyl)-1H-tetrazol-1-yl]phenyl]methyl]-2-phenyl-, dihydrochloride, (2S-cis)-
- Gr 205171A
- GR 205171 Dihydrochloride
- N-{2-methoxy-5-[5-(trifluoromethyl)-1H-tetrazol-1-yl]benzyl}-2-phenylpiperidin-3-amine dihydrochloride
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
N-[[2-Methoxy-5-[5-(Trifluoromethyl)Tetrazol-1-Yl]Phenyl]Methyl]-2-Phenylpiperidin-3-Amine Dihydrochloride REF: 3D-FM102827CAS: 168266-51-1 | Min. 95% | A consultar | Mar 21 Ene 25 | |
Vofopitant dihydrochloride REF: TM-T13329LCAS: 168266-51-1 | 98.99% | A consultar | Mar 11 Mar 25 |
N-[[2-Methoxy-5-[5-(Trifluoromethyl)Tetrazol-1-Yl]Phenyl]Methyl]-2-Phenylpiperidin-3-Amine Dihydrochloride
CAS:168266-51-1
N-[[2-Methoxy-5-[5-(Trifluoromethyl)Tetrazol-1-Yl]Phenyl]Methyl]-2-Phenylpiperidin-3-Amine Dihydrochloride is a drug that belongs to the group of antimuscarinic drugs. It may …
Fórmula:
C21H25Cl2F3N6O
Pureza:
Min. 95%
Peso molecular:
505.36 g/mol
Ref: 3D-FM102827
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
Vofopitant dihydrochloride
CAS:168266-51-1
Vofopitant dihydrochloride (GR 205171A) is a tachykinin NK1 receptor antagonist and a potential compound for …
Fórmula:
C21H25Cl2F3N6O
Pureza:
98.99%
Forma y color:
Solid
Peso molecular:
505.36
Ref: TM-T13329L
1mg | 96,00 € | ||
5mg | 229,00 € | ||
10mg | 368,00 € | ||
25mg | 695,00 € | ||
50mg | 1.039,00 € | ||
100mg | 1.419,00 € | ||
500mg | 2.753,00 € | ||
1mL*10mM (DMSO) | 260,00 € |
Entrega estimada en Estados Unidos, el Martes 11 de Marzo de 2025